Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Bone Therapeutics SA
0:44
Addressing issues associated with bringing iSPC-derived MSCs to the clinic
Tony Ting
• 26 Jan 2022
1:48
Enhancing the therapeutic capacity of MSCs
Tony Ting
• 26 Jan 2022
0:39
Evaluating the development of iSPC-derived MSCs
Tony Ting
• 26 Jan 2022
2:32
The ISCT’s ongoing battle against unproven cell & gene therapies
Miguel Forte
• 5 Oct 2021
1:45
Developing iPSC-derived MSCs for therapeutic purposes
Miguel Forte
• 5 Oct 2021
2:04
Learnings from the COVID-19 pandemic for the advanced therapies sector
Miguel Forte
• 5 Oct 2021
3:14
Addressing the unproven cell-based therapy market
Miguel Forte
• 26 May 2021
3:45
Improving patient access to cell & gene therapies
Miguel Forte
• 26 May 2021
4:54
Off-the-shelf cell therapy for bone indications: ALLOB & JTA-004
Miguel Forte
• 26 May 2021
